Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
The present invention relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with HDAC6, having a Formulae I or Formula II:where R, L, X1, X2, X3, X4, X5, Y1, Y2, Y3, and Y4 are described herein.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
22.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!